The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Proposed mechanism for monomethylarsonate reductase activity of human omega-class glutathione transferase GSTO1-1
Open accessPublished version of a preprint
Abstract
Contamination of drinking water with toxic inorganic arsenic is a major public health issue. The mechanisms of enzymes and transporters in arsenic elimination are therefore of interest. The human omega-class glutathione transferases have been previously shown to possess monomethylarsonate (V) reductase activity. To further understanding of this activity, molecular dynamics of human GSTO1-1 bound to glutathione with a monomethylarsonate isostere were simulated to reveal putative monomethylarsonate binding sites on the enzyme. The major binding site is in the active site, adjacent to the glutathione binding site. Based on this and previously reported biochemical data, a reaction mechanism for this enzyme is proposed. Further insights were gained from comparison of the human omega-class GSTs to homologs from a range of animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Characterization of the human Omega class glutathione transferase genes and associated polymorphisms
Whitbread, A. K., Tetlow, N., Eyre, H. J., Sutherland, G. R., & Board, P. G. (2003) · Pharmacogenetics · doi:10.1097/00008571-200303000-00003 · Cited by 181
Flagged first, then by citations
Research works printed but not linked: 36
- Ratnaike, 2003, Acute and chronic arsenic toxicity, Postgrad. Med., 79, 391, 10.1136/pmj.79.933.391 · DOI · Paper page
- Aposhian, 1997, Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity, Annu. Rev. Pharmacol. Toxicol., 37, 397, 10.1146/annurev.pharmtox.37.1.397 · DOI
- Hayakawa, 2005, A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19, Arch. Toxicol., 79, 183, 10.1007/s00204-004-0620-x · DOI
- Khairul, 2017, Metabolism, toxicity and anticancer activities of arsenic compounds, Oncotarget, 8, 23905, 10.18632/oncotarget.14733 · DOI
- Zakharyan, 2001, Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily, Chem. Res. Toxicol., 14, 1051, 10.1021/tx010052h · DOI
- Oakley, 2011, Glutathione transferases: a structural perspective, Drug Metab. Rev., 43, 138, 10.3109/03602532.2011.558093 · DOI
- Chowdhury, 2006, Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration, Toxicol. Appl. Pharmacol., 216, 446, 10.1016/j.taap.2006.06.014 · DOI
- Whitbread, 2005, Characterization of the omega class of glutathione transferases, Methods Enzymol., 401, 78, 10.1016/S0076-6879(05)01005-0 · DOI
- Schmuck, 2005, Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases, Pharmacogenetics Genom., 15, 493, 10.1097/01.fpc.0000165725.81559.e3 · DOI
- Beebe-Dimmer, 2012, Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study, Environ. Health, 11, 43, 10.1186/1476-069X-11-43 · DOI
- Escobar-García, 2012, Arch. Toxicol., 86, 857, 10.1007/s00204-012-0802-x · DOI
- Board, 2000, Identification, characterization and crystal structure of the omega class glutathione transferases, J. Biol. Chem., 275, 24798, 10.1074/jbc.M001706200 · DOI
- Zhou, 2012, Structural insights into the dehydroascorbate reductase activity of human omega-class glutathione transferases, J. Mol. Biol., 420, 190, 10.1016/j.jmb.2012.04.014 · DOI
- Hayes, 2005, Glutathione transferases, Annu. Rev. Pharmacol. Toxicol., 45, 51, 10.1146/annurev.pharmtox.45.120403.095857 · DOI
- Atkinson, 2009, Glutathione transferases are structural and functional outliers in the thioredoxin fold, Biochemistry, 48, 11108, 10.1021/bi901180v · DOI
- Menon, 2014, Glutathione transferase omega 1 is required for the lipopolysaccharide-stimulated induction of NADPH oxidase 1 and the production of reactive oxygen species in macrophages, Free Radic. Biol. Med., 73, 318, 10.1016/j.freeradbiomed.2014.05.020 · DOI
- Hughes, 2019, Glutathione transferase omega-1 regulates NLRP3 inflammasome activation through NEK7 deglutathionylation, Cell Rep., 29, 151, 10.1016/j.celrep.2019.08.072 · DOI
- Tsuboi, 2011, Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance, J. Am. Chem. Soc., 133, 16605, 10.1021/ja2066972 · DOI
- Dai, 2019, Structure-based design of N-(5-Phenylthiazol-2-yl)acrylamides as novel and potent glutathione S-transferase omega 1 inhibitors, J. Med. Chem., 62, 3068, 10.1021/acs.jmedchem.8b01960 · DOI
- Xie, 2020, Development of benzenesulfonamide derivatives as potent glutathione transferase omega-1 inhibitors, J. Med. Chem., 63, 2894, 10.1021/acs.jmedchem.9b01391 · DOI
- Pang, 2014, Low-mass molecular dynamics simulation: a simple and generic technique to enhance configurational sampling, Biochem. Biophys. Res. Commun., 452, 588, 10.1016/j.bbrc.2014.08.119 · DOI
- Phillips, 2020, Scalable molecular dynamics on CPU and GPU architectures with NAMD, J. Chem. Phys., 153
- Robertson, 2015, Improved peptide and protein torsional energetics with the OPLSAA force field, J. Chem. Theor. Comput., 11, 3499, 10.1021/acs.jctc.5b00356 · DOI
- Dodda, 2017, LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands, Nucleic Acids Res., 45, W331, 10.1093/nar/gkx312 · DOI
- Humphrey, 1996, VMD: visual molecular dynamics, J. Mol. Graph., 14, 33, 10.1016/0263-7855(96)00018-5 · DOI · Paper page
- Larkin, 2007, Clustal W and clustal X version 2.0, Bioinformatics, 23, 2947, 10.1093/bioinformatics/btm404 · DOI
- Jurrus, 2018, Improvements to the APBS biomolecular solvation software suite, Protein Sci., 27, 112, 10.1002/pro.3280 · DOI
- Saisawang, 2019, Glutathione transferase Omega 1-1 (GSTO1-1) modulates Akt and MEK1/2 signaling in human neuroblastoma cell SH-SY5Y, Proteins, 87, 588, 10.1002/prot.25683 · DOI
- Cullen, 1984, The reaction of methylarsenicals with thiols: some biological implications, J. Inorg. Biochem., 21, 179, 10.1016/0162-0134(84)83002-0 · DOI
- Brock, 2013, Structural insights into omega-class glutathione transferases: a snapshot of enzyme reduction and identification of a non-catalytic ligandin site, PLoS One, 8, 10.1371/journal.pone.0060324 · DOI
- Rosen, 2020, Isofunctional clustering and conformational analysis of the arsenate reductase superfamily reveals nine distinct clusters, Biochemistry, 59, 4262, 10.1021/acs.biochem.0c00651 · DOI
- DeMel, 2004, Arginine 60 in the ArsC arsenate reductase of E. coli plasmid R773 determines the chemical nature of the bound As(III) product, Protein Sci., 13, 2330, 10.1110/ps.04787204 · DOI
- LoBello, 1997, Multifunctional role of Tyr 108 in the catalytic mechanism of human glutathione transferase P1-1. Crystallographic and kinetic studies on the Y108F mutant enzyme, Biochemistry, 36, 6207, 10.1021/bi962813z · DOI
- Ji, 1994, Structure and function of the xenobiotic substrate binding site of a glutathione S-transferase as revealed by X-ray crystallographic analysis of product complexes with the diastereomers of 9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene, Biochemistry, 33, 1043, 10.1021/bi00171a002 · DOI
- Chen, 2015, Therapeutic and analytical applications of arsenic binding to proteins, Metallomics, 7, 39, 10.1039/C4MT00222A · DOI
- de Thé, 2017, Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure, Cancer Cell, 32, 552, 10.1016/j.ccell.2017.10.002 · DOI
Metadata
- Authors
- Oakley, A. J.
- Affiliations
- University of Wollongong (AU)
- Corresponding author
- Oakley, Aaron J.
- ORCID
- Oakley, Aaron J.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 590
- Pages
- 7-13
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W4225861523
- Cited by
- 3
- References
- 2
- Citations by year
- 2025: 2 · 2022: 1
- FWCI
- 0.08
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Biochemical and Biophysical Research Communications (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Figshare (submittedVersion)
- Funders
- National Health and Medical Research Council (APP1124673, APP1156455)
- National Institutes of Health (R01-GM129325)
- National Institute of Allergy and Infectious Diseases
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Physical Sciences › Environmental Science › Environmental Chemistry › Arsenic contamination and mitigation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- arsenic detoxification, inorganic arsenic, glutathione binding site, enzyme mechanism, molecular dynamics simulation, active site
- MeSH terms
- Amino Acid Sequence, Glutathione Transferase, Humans, Models, Molecular, Oxidoreductases, Catalytic Domain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review